Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARK7 | Q99497 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 9/20 | 0.43 |
| ▸ | CA2 | P00918 | 9/20 | 0.43 |
| ▸ | CA9 | Q16790 | 9/20 | 0.43 |
| ▸ | CA4 | P22748 | 6/20 | 0.43 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL127843 | 0.96 | PARK7 (0.44) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL127852 | 0.87 | PARK7 (0.55) | PARK7CA1CA2CA9CA12 | |
| SCHEMBL125865 | 0.83 | PARK7 (0.54) | PARK7CA1CA2CA9CA12 | |
| SCHEMBL12744278 | 0.83 | CYP1B1 (0.46) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL125917 | 0.82 | CYP1B1 (0.59) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL12744285 | 0.82 | CYP1B1 (0.46) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL25269189 | 0.79 | CYP1B1 (0.62) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL13784290 | 0.79 | CHRM5 (0.45) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL14000758 | 0.79 | CA1 (0.48) | PARK7CA1CA2CA9CA4 | |
| SCHEMBL125857 | 0.79 | CYP1B1 (0.58) | PARK7CA1CA2CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| US-20150123090-A1 | METHOD FOR THE DEPOSITION OF AN ORGANIC MATERIAL | BASF SE (DE) | 2015-05-07 | — | — | US | disclosed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-8309728-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2012-11-13 | — | — | US | disclosed |
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-8084603-B2 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF AKTIENGESELLSCHAFT (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| WO-2007074137-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | BASF SE (DE) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059168-A1 | NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES AND THEIR USE AS SEMICONDUCTORS | TST, NANS, NCDN | PARK7 2043/4885CA1 573/4885CA2 362/4885 |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | ADSL, ALAD, EED | PARK7 3506/4885CA1 291/4885CA2 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.